Short, direct answers to the questions that come up in nearly every investor conversation: terms, timeline, structure, eligibility, and what happens next.
These are indicative responses, written to answer quickly and consistently. Anything here that bears on a decision should be confirmed against the definitive documents in the 09 Fundraise and 08 Corporate folders, which govern.
| ASK | INDICATIVE RESPONSE |
|---|---|
| What are you raising? | $3M pre-seed, $10M pre-money |
| When does it open? | July 1, 2026 |
| Minimum raise? | $3M minimum |
| What is the instrument? | Priced unit offering: each $1,000 unit = 1 redeemable preferred ($500 face) + 1,000 common ($500 at $0.50) + a half warrant at $1.50 |
| Already committed? | $300K ($50K angel + $250K first tranche) |
| Investor protections? | NVCA-aligned: 1x non-participating preference, broad-based weighted-average anti-dilution, pro-rata, information rights |
| Tax treatment? | BC EBC 30% tax credit; structured for TFSA / RRSP eligibility |
The definitive round terms, unit composition, and redemption schedule are in the Capital Structure Memorandum (document 08.1) and the 09 Fundraise documents. This page is a convenience summary, not an offer; the subscription documents prepared with Capiche govern any investment.
The founders read every access request and every introduction personally. To begin a subscription, request a management call, or raise a question this room does not answer, email founders@kcs-capital.com. The round opens July 1, 2026.
Indicative responses prepared by the founders as of June 2026 for convenience only. They do not constitute an offer to sell or a solicitation to buy securities; any investment is made solely through the definitive subscription documents, which govern. Forward-looking statements are subject to material change.
Prepared for approved data room members. This document does not constitute an offer to sell securities or a solicitation of an offer to buy securities. 4orm Finance Holdings Inc. is the parent entity of 4orm OpCo, 4ormEx OpCo, and 4orm Trust Co; technology is developed by KCS Capital, an independent research and development firm.